In addition, the dual blockade of PI3Ka and CDK4/6 not only significantly enhanced the induction of apoptosis, cell-cycle arrest, and tumor immunogenicity but also induced immunogenic cell death in human triple-negative breast cancer (TNBC) cells [30]. This evidence concerns the gene CDK4 and triple-negative breast carcinoma.